|
Serotonin syndrome |
Neuroleptic malignant syndrome |
Inciting drug |
Serotonergic agent |
Dopamine antagonist |
Onset |
Usually < 24 h |
Gradual onset (days to weeks) |
Vitals |
Hypertension, tachycardia, tachypnea, hyperthermia (<41℃) |
Hypertension, tachycardia, tachypnea, hyperthermia (>41℃) |
Core symptoms |
Agitation, diarrhea, diaphoresis, tremors |
Dysphagia, hypersalivation |
Neuromuscular signs |
Hyperreflexia, clonus, mydriasis |
Bradykinesia, hyporeflexia, lead-pipe rigidity |
Lab findings |
Most commonly no significant lab abnormalities |
Increase in creatine kinase, leukocytosis, low serum iron |